183 related articles for article (PubMed ID: 37007509)
1. Acupuncture improved hepatic steatosis in HFD-induced NAFLD rats by regulating intestinal microbiota.
Wang H; Wang Q; Liang C; Pan L; Hu H; Fang H
Front Microbiol; 2023; 14():1131092. PubMed ID: 37007509
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.
Tang W; Yao X; Xia F; Yang M; Chen Z; Zhou B; Liu Q
Oxid Med Cell Longev; 2018; 2018():7261619. PubMed ID: 30671174
[TBL] [Abstract][Full Text] [Related]
3. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
4. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
Shen SH; Zhong TY; Peng C; Fang J; Lv B
BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
[TBL] [Abstract][Full Text] [Related]
5. Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver Axis.
Yang H; Feng L; Xu L; Jiang D; Zhai F; Tong G; Xing Y
Biomed Res Int; 2022; 2022():4801695. PubMed ID: 35837380
[TBL] [Abstract][Full Text] [Related]
6. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
[TBL] [Abstract][Full Text] [Related]
7. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
8. Sodium butyrate ameliorates non-alcoholic fatty liver disease by upregulating miR-150 to suppress CXCR4 expression.
Zhang N; Qu Y; Qin B
Clin Exp Pharmacol Physiol; 2021 Aug; 48(8):1125-1136. PubMed ID: 33721354
[TBL] [Abstract][Full Text] [Related]
9. [Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].
Zhong FW; Li GX; Zeng L
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2500-2508. PubMed ID: 35531697
[TBL] [Abstract][Full Text] [Related]
10. Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut-Liver Axis in High-Fat Diet-Fed Rats.
Zhao H; Gao X; Liu Z; Zhang L; Fang X; Sun J; Zhang Z; Sun Y
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432531
[TBL] [Abstract][Full Text] [Related]
11. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
[TBL] [Abstract][Full Text] [Related]
12. [Acupuncture improves hepatic lipid metabolism by suppressing oxidative stress in obese nonalcoholic fatty liver disease rats].
Wang HY; Liang CM; Cui JW; Pan L; Hu H; Fang HJ
Zhen Ci Yan Jiu; 2019 Mar; 44(3):189-94. PubMed ID: 30945501
[TBL] [Abstract][Full Text] [Related]
13. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
[No Abstract] [Full Text] [Related]
14. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
15. Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression.
Zhou Y; Zheng T; Chen H; Li Y; Huang H; Chen W; Du Y; He J; Li Y; Cao J; Nie Y; Zhou Y
Cell Physiol Biochem; 2018; 51(5):2123-2135. PubMed ID: 30522122
[TBL] [Abstract][Full Text] [Related]
16. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Wang P; Wang J; Li D; Ke W; Chen F; Hu X
J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
[TBL] [Abstract][Full Text] [Related]
17. The Therapeutic Efficacy of Curcumin vs. Metformin in Modulating the Gut Microbiota in NAFLD Rats: A Comparative Study.
Li R; Yao Y; Gao P; Bu S
Front Microbiol; 2020; 11():555293. PubMed ID: 33584555
[TBL] [Abstract][Full Text] [Related]
18. Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats.
Ji G; Zhao X; Leng L; Liu P; Jiang Z
Lipids Health Dis; 2011 Jan; 10():23. PubMed ID: 21269482
[TBL] [Abstract][Full Text] [Related]
19. Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice.
Yang M; Wang H; Bukhari I; Zhao Y; Huang H; Yu Y; Sun X; Mi Y; Mei L; Zheng P
Front Nutr; 2023; 10():1121203. PubMed ID: 37545590
[TBL] [Abstract][Full Text] [Related]
20. Effect of Jiangan-Jiangzhi Pill on Gut Microbiota and Chronic Inflammatory Response in Rats with Non-Alcoholic Fatty Liver.
Zhao Z; Wang J; Ren W; Bian Y; Wang Y; Wang L; Guo L; Lei J; Jia J; Miao J
Chem Biodivers; 2022 May; 19(5):e202100987. PubMed ID: 35324083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
